SCHEMBL6977547

SCHEMBL6977547

NCC1CCN(C(=O)c2cccnc2Cl)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.62
POLB P06746 3/20 0.54
CYP2C9 P11712 3/20 0.48
MAPK14 Q16539 3/20 0.48
HTR2B P41595 2/20 0.48
PRKCQ Q04759 2/20 0.47
CCR3 P51677 1/20 0.45
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RAB9A P51151 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764827 0.81 POLB (0.60) CYP2C19POLBLMNASMN1; SMN2RAB9A
SCHEMBL1865263 0.79 POLB (0.63) CYP2C19POLBCYP2C9LMNASMN1; SMN2
SCHEMBL23573213 0.78 CYP2C19 (0.61) CYP2C19POLBLMNASMN1; SMN2RAB9A
SCHEMBL1976542 0.77 POLB (0.65) CYP2C19POLBLMNASMN1; SMN2MAPT
SCHEMBL2002157 0.77 POLB (0.61) CYP2C19POLBLMNASMN1; SMN2RAB9A
SCHEMBL6981272 0.77 L3MBTL1 (0.67) CYP2C19CYP2C9PRKCQSMN1; SMN2CHRM2
SCHEMBL3764825 0.77 POLB (0.61) CYP2C19POLBLMNASMN1; SMN2MAPT
SCHEMBL12833234 0.76 RXFP1 (0.63) CYP2C19POLBLMNASMN1; SMN2MAPT
SCHEMBL855339 0.76 POLB (0.60) CYP2C19POLBLMNASMN1; SMN2MAPT
SCHEMBL30073359 0.76 POLB (0.60) CYP2C19POLBLMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
CN-1071755-C Heterocyclylcarboxamide derivatives and their use as therapeutic agents KNOLL AG (DE) 2001-09-26 CN disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed